Refining endpoints in brain tumor clinical trials

被引：38

作者：

Meyers, Christina A. ^{[1
]}

Rock, Edwin P. ^{[2
]}

Fine, Howard A. ^{[3
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA

[2] Otsuka Pharmaceut Dev & Commercializat Inc, Rockville, MD USA

[3] NCI, Neurooncol Branch, Bethesda, MD 20892 USA

来源：

JOURNAL OF NEURO-ONCOLOGY | 2012年 / 108卷 / 02期

关键词：

Brain cancer; Clinical trials; Neurocognitive function; NEUROCOGNITIVE FUNCTION; COGNITIVE FUNCTION; PROGRESSION; RADIATION; CANCER; GLIOMA;

D O I：

10.1007/s11060-012-0813-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

As targeted therapies advance treatment for brain tumors, standard clinical trial endpoints of survival, progression free survival and radiographic response have become insufficient to capture clinical benefit. Brain cancer is a malignancy with neurodegenerative features. In this setting prolongation of life and/or radiographic stability are less clinically meaningful if neurocognitive function substantially declines. Hence evaluation of new therapeutic strategies should routinely include periodic assessment of neurocognitive function.

引用

页码：227 / 230

页数：4

共 50 条

[41] Current Clinical Trials in Traumatic Brain Injury [J].

Ahmed, Zubair .

BRAIN SCIENCES, 2022, 12 (05)

[42] Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series [J].

Hjermstad, Marianne J. ;

Jakobsen, Gunnhild ;

Arends, Jann ;

Balstad, Trude ;

Brown, Leo R. ;

Bye, Asta ;

Coats, Andrew J. S. ;

Dajani, Olav F. ;

Dolan, Ross D. ;

Fallon, Marie T. ;

Greil, Christine ;

Grzyb, Alexandra ;

Kaasa, Stein ;

Koteng, Lisa H. ;

May, Anne M. ;

Mcdonald, James ;

Ottestad, Inger ;

Philips, Iain ;

Roeland, Eric J. ;

Sayers, Judith ;

Simpson, Melanie R. ;

Skipworth, Richard J. E. ;

Solheim, Tora S. ;

Sousa, Mariana S. ;

Vagnildhaug, Ola M. ;

Laird, Barry J. A. .

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2024, 15 (03) :794-815

[43] Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series [J].

Mcdonald, James ;

Sayers, Judith ;

Anker, Stefan D. ;

Arends, Jann ;

Balstad, Trude ;

Baracos, Vickie ;

Brown, Leo ;

Bye, Asta ;

Dajani, Olav ;

Dolan, Ross ;

Fallon, Marie T. ;

Fraser, Eilidh ;

Griel, Christine ;

Grzyb, Aleksandra ;

Hjermstad, Marianne ;

Jamal-Hanjani, Mariam ;

Jakobsen, Gunnhild ;

Kaasa, Stein ;

Mcmillan, Donald ;

Maddocks, Matthew ;

Philips, Iain ;

Ottestad, Inger O. ;

Reid, Kieran F. ;

Sousa, Mariana S. ;

Simpson, Melanie R. ;

Vagnildhaug, Ola Magne ;

Skipworth, Richard J. E. ;

Solheim, Tora S. ;

Laird, Barry J. A. .

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2023, :1932-1948

[44] Cancer clinical trials with efficacy and toxicity endpoints: A simulation study to compare two nonparametric methods [J].

Letierce, Alexia ;

Tubert-Bitter, Pascale .

ADVANCES IN STATISTICAL METHODS FOR THE HEALTH SCIENCES: APPLICATIONS TO CANCER AND AIDS STUDIES, GENOME SEQUENCE ANALYSIS, AND SURVIVAL ANALYSIS, 2007, :335-+

[45] Utilising Natural Language Processing to Identify Brain Tumor Patients for Clinical Trials [J].

Booker, James ;

Penn, Jack ;

Noor, Kawsar ;

Dobson, Richard J. B. ;

Fersht, Naomi ;

Funnell, Jonathan P. ;

Hill, Ciaran S. ;

Khan, Danyal Z. ;

Newall, Nicola ;

Searle, Tom ;

Sinha, Siddharth ;

Thorne, Lewis ;

Williams, Simon C. ;

Kosmin, Michael ;

Marcus, Hani J. .

WORLD NEUROSURGERY, 2025, 197

[46] Examiner accuracy in cognitive testing in multisite brain-tumor clinical trials: an analysis from the Alliance for Clinical Trials in Oncology [J].

Cerhan, Jane H. ;

Anderson, S. Keith ;

Butts, Alissa M. ;

Porter, Alyx B. ;

Jaeckle, Kurt ;

Galanis, Evanthia ;

Brown, Paul D. .

NEURO-ONCOLOGY PRACTICE, 2019, 6 (04) :283-288

[47] Analysis and Design of Clinical Trials Using Additive Hazards Survival Endpoints [J].

McDaniel, Lee S. ;

Yu, Menggang ;

Chappell, Rick .

STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2019, 11 (03) :274-282

[48] Blinded sample size recalculation in clinical trials with binary composite endpoints [J].

Sander, Anja ;

Rauch, Geraldine ;

Kieser, Meinhard .

JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2017, 27 (04) :705-715

[49] Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations [J].

Turk, Dennis C. ;

Dworkin, Robert H. ;

McDermott, Michael P. ;

Bellamy, Nicholas ;

Burke, Laurie B. ;

Chandler, Julie M. ;

Cleeland, Charles S. ;

Cowan, Penney ;

Dimitrova, Rozalina ;

Farrar, John T. ;

Hertz, Sharon ;

Heyse, Joseph F. ;

Iyengar, Smriti. ;

Jadad, Alejandro R. ;

Jay, Gary W. ;

Jermano, John A. ;

Katz, Nathaniel P. ;

Manning, Donald C. ;

Martin, Susan ;

Max, Mitchell B. ;

McGrath, Patrick ;

McQuay, Henry J. ;

Quessy, Steve ;

Rappaport, Bob A. ;

Revicki, Dennis A. ;

Rothman, Margaret ;

Stauffer, Joseph W. ;

Svensson, Ola ;

White, Richard E. ;

Witter, James .

PAIN, 2008, 139 (03) :485-493

[50] Diabetic nephropathy as a model for the use of renal structural endpoints in clinical trials [J].

Mauer, M ;

Fioretto, P .

KIDNEY INTERNATIONAL, 1997, :S155-S158

← 1 2 3 4 5 →